Hims & Hers Health
HIMS
512 hedge funds and large institutions have $11.3B invested in Hims & Hers Health in 2025 Q3 according to their latest regulatory filings, with 102 funds opening new positions, 202 increasing their positions, 153 reducing their positions, and 96 closing their positions.
118% more capital inflows, than outflows
Capital inflows: $2.36B | Capital outflows: $1.08B
32% more repeat investments, than reductions
Existing positions increased: 202 | Existing positions reduced: 153
10.44% more ownership
Funds ownership: 81.44% → 91.88% (+10%)
6% more first-time investments, than exits
New positions opened: 102 | Existing positions closed: 96
0% more funds holding
Funds holding: 511 → 512 (+1)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
21% less call options, than puts
Call options by funds: $1.73B | Put options by funds: $2.19B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$771M |
| 2 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
+$139M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$130M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$128M |
| 5 |
Renaissance Technologies
New York
|
+$114M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
SRS Investment Management
New York
|
-$199M |
| 2 |
D.E. Shaw & Co
New York
|
-$96.7M |
| 3 |
QC
Quadrature Capital
London,
United Kingdom
|
-$63.6M |
| 4 |
Squarepoint
New York
|
-$54.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$50M |
HIMS Hedge Fund Activity: Q3 2025 in Review
512 of the 7,647 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q3 2025, worth a combined $11.3B — up 30% from $8.75B a quarter earlier.
Buyers outnumbered sellers: 102 funds opened new HIMS positions and 96 closed out — a net gain of 6 holders — while 202 added to existing stakes and 153 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $771M. The largest seller was SRS Investment Management, exiting entirely with an estimated $199M sold.
- 512 institutional investors held Hims & Hers Health (HIMS) as of Q3 2025, up from 511 in Q2 2025.
- Funds reported $11.3B of Hims & Hers Health stock for Q3 2025, up 30% quarter-over-quarter.
- 102 funds opened new Hims & Hers Health positions in Q3 2025 and 96 closed out, a net change of +6 holders.
- The largest Hims & Hers Health buyer in Q3 2025 was JP Morgan Chase, an estimated $771M added.
- The largest Hims & Hers Health seller in Q3 2025 was SRS Investment Management, an estimated $199M sold.
Based on aggregated 13F filings for Q3 2025.